Tempsens Instruments (India) IPO 2026: GMP, Price Band, Dates, Lot Size & Review
The Tempsens Instruments (India) IPO is set to enter the Indian primary market as a Mainboard IPO, giving investors an opportunity to participate in a company operating in the industrial temperature-sensing, thermal engineering and specialised cable solutions space. The company is scheduled to open its public issue on August 20, 2026, and the issue will remain open for subscription until August 24, 2026. The IPO has a total issue size of ₹650 crore, with a price band of ₹285 to ₹300 per equity share.
Tempsens Instruments has built its business around industrial temperature measurement and thermal solutions used across sectors where accurate temperature control is critical. The company has also developed an international presence, making the IPO relevant for investors looking beyond conventional consumer-facing businesses.
Tempsens Instruments IPO 2026: Key Details
| Particulars | Details |
|---|---|
| Company | Tempsens Instruments (India) Ltd. |
| IPO Type | Mainboard IPO |
| Issue Size | ₹650 Crore |
| Fresh Issue | ₹95 Crore |
| Offer for Sale | ₹555 Crore |
| IPO Open Date | August 20, 2026 |
| IPO Close Date | August 24, 2026 |
| Price Band | ₹285 – ₹300 per Share |
| Face Value | ₹4 per Share |
| Lot Size | 50 Shares |
| Minimum Investment | ₹15,000 |
| Allotment Date | August 25, 2026 |
| Listing Date | August 28, 2026 |
| Listing Exchanges | NSE & BSE |
| Book Running Lead Managers | ICICI Securities, JM Financial |
| Registrar | KFin Technologies |
The issue comprises a fresh issue of ₹95 crore and an offer for sale of ₹555 crore. At the upper price band of ₹300, one lot of 50 shares requires a minimum investment of ₹15,000.
About Tempsens Instruments (India) Limited
Tempsens Instruments (India) Limited was incorporated in 1990 and operates in thermal engineering and industrial instrumentation. Its product portfolio includes temperature sensors, thermocouples, resistance temperature detectors (RTDs), thermowells, heating elements, industrial furnaces and specialised cables.
The company serves industries where temperature monitoring and thermal management are essential for operational efficiency and safety. Its solutions are relevant to industries such as power, petrochemicals, glass, metals and other industrial applications.
According to industry information cited in IPO research, Tempsens is the largest manufacturer of contact and non-contact temperature sensors in India by revenue, with an approximately 10% share of the temperature-sensor segment in FY2025. The company has also established an international customer base and exports its products to more than 70 countries.
Tempsens Instruments IPO GMP
The Tempsens Instruments IPO GMP (Grey Market Premium) is an unofficial market indicator that can reflect investor sentiment before the shares are listed. However, GMP is not regulated by stock exchanges or SEBI and can change quickly depending on market conditions, subscription demand and overall sentiment.
Investors should therefore avoid considering GMP alone when evaluating the IPO. The final listing performance can differ significantly from grey-market expectations.
For the latest Tempsens Instruments IPO GMP, investors should check the latest available market data close to the IPO opening and listing dates rather than relying on old GMP figures.
Tempsens Instruments IPO Financial Performance
The company’s financial performance has shown considerable improvement over recent years. For FY2025, Tempsens Instruments reported revenue from operations of approximately ₹378.53 crore, compared with ₹274.81 crore in FY2024 and ₹236.94 crore in FY2023.
Profit after tax increased to approximately ₹62.56 crore in FY2025, compared with ₹40.92 crore in FY2024 and ₹33.23 crore in FY2023. EBITDA also increased substantially, reaching approximately ₹97.32 crore in FY2025.
This indicates a positive growth trend in both revenue and profitability. The company also reported an EBITDA margin of around 25.45% for FY2025, while its debt-to-equity ratio was approximately 0.16x.
Recent financial data reported for the year ended March 2026 also indicates continued business growth, with total income of about ₹430.15 crore and profit after tax of ₹63.41 crore.
Use of Tempsens Instruments IPO Proceeds
The fresh issue component of the IPO is intended to support the company’s business and financial objectives. The company plans to use proceeds towards capital expenditure related to electrical heating solutions and specialised cable solutions. A portion is also intended for pre-payment or scheduled repayment of certain outstanding borrowings, with the balance allocated for general corporate purposes.
Expansion of manufacturing capabilities could help the company address growing demand and strengthen its position in industrial thermal solutions.
Strengths of Tempsens Instruments IPO
One of the key strengths of Tempsens Instruments is its specialised position in the industrial temperature-sensing market. Its products are used in applications where precision, reliability and durability are important.
The company also benefits from an established operating history, a diversified product portfolio and an international customer base. Its financial performance has shown growth in revenue, EBITDA and PAT, while its relatively moderate debt-to-equity ratio provides some financial flexibility.
Another potential growth driver is international expansion. The company has subsidiaries and operations connected with markets including Germany, Indonesia and the UAE, providing opportunities to increase its global presence.
Risks Investors Should Consider
Despite the company’s growth prospects, investors should also evaluate the associated risks before applying.
The IPO has a substantial Offer for Sale component of ₹555 crore, compared with a fresh issue of ₹95 crore. This means a large portion of the issue proceeds will go to existing selling shareholders rather than directly to the company.
Investors should also consider risks associated with industrial demand, raw-material costs, foreign-market exposure, competition, customer concentration and the company’s ability to execute planned expansion projects.
GMP should not be treated as a guarantee of listing gains. Investors should review the company’s RHP, financial statements, valuation, industry conditions and risk factors before making an investment decision.
Tempsens Instruments IPO: Should You Apply?
The Tempsens Instruments IPO presents an interesting opportunity in a specialised industrial engineering segment. The company’s established presence, diversified thermal product portfolio, international operations and improving financial performance are some of the factors investors may consider positively.
At the same time, the high proportion of OFS, valuation at the IPO price band, industry risks and execution requirements should be carefully evaluated.
The IPO may appeal to investors looking for exposure to a niche industrial manufacturing business with potential for domestic and international expansion. However, whether the IPO is suitable depends on an investor’s risk appetite, investment horizon and independent assessment of valuation.
Conclusion
The Tempsens Instruments (India) IPO 2026 is one of the notable Mainboard IPOs scheduled for August 2026. With an issue size of ₹650 crore, a price band of ₹285–₹300 and a minimum investment of ₹15,000, the IPO will be closely watched by retail and institutional investors.
The company’s strong position in industrial temperature sensors, growing revenue and profitability, export presence and expansion plans provide important points for investors to examine. However, investors should not base their decision solely on IPO GMP or expected listing gains.
For the latest Tempsens Instruments IPO GMP, subscription status, allotment updates, listing information and IPO review, investors should follow updated information as the issue progresses.
Disclaimer: This article is for informational and educational purposes only and should not be considered investment advice. IPO investments are subject to market risks. Investors should read the company’s RHP and consult a qualified financial adviser before making investment decisions.